Last Price
271.24
Today's Change
+26.26 (10.71%)
Day's Change
254.44 - 275.52
Trading Volume
797,476
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. James R. Hollingshead Ph.D. Dr. James R. Hollingshead Ph.D.
Full Time Employees: 3,000 3,000
IPO Date: 2007-05-15 2007-05-15
CIK: 0001145197 0001145197
ISIN: US45784P1012 US45784P1012
CUSIP: 45784P101 45784P101
Beta: 1.21 1.21
Last Dividend: 0.00 0.00
Dcf Diff: 338.80 338.80
Dcf: -65.65 -65.65
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.